The discovery of copy number variation in healthy individuals is far from complete, and due to the resolution of detection systems used, the majority of loci reported so far are relatively large (~65% > 10kb). Applying a two-stage high-resolution array CGH approach to analyse 50 healthy Caucasian males from northern France, we discovered 2208 copy number variants (CNVs) detected by more than one consecutive probe. These clustered into 1469 copy number variant regions (CNVRs), of which 721 are thought to be novel. The majority of these are small (median size 4.4kb) and most have common boundaries, with a coefficient of variation less than 0.1 for 83% of end-points in those observed in multiple samples. Only 6% of the CNVRs analysed showed evidence of both copy number losses and gains at the same site. A further 6089 variants were detected by single probes: 48% of these were observed in more than one individual.
Introduction
Genomic copy number variation is much more common and involves a much greater proportion of the genome than previously realised (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . In addition to the intrinsic interest of elucidating the structure, evolution and current variability of the human genome, research into copy number variants (CNVs) is important as they may contribute to susceptibility to common diseases. It is essential to characterise and catalogue genomic copy number variation in healthy individuals as a foundation for assessing its putative implications for disease-associated phenotypes relevant to common complex disorders. Particular CNVs are already reported to be associated with susceptibility to HIV, glomerulonephritis and autism (11, 12, 13, 14) . CNVs are also of great interest to clinical cytogeneticists, who need to know what variation is 'normal' in the human genome in order to be able to determine which submicroscopic aberrations may be responsible for the rare, but very abnormal phenotypes in young individuals, which are known as genomic disorders (15) .
The CNVs reported so far have been documented in the TCAG Database of Genomic Variants (16) , which at the time of writing contains over 3600 copy number variant loci. The overlap between CNVs reported by the various studies is not large (17) , implying that information on copy number variability remains significantly incomplete (18) . This is likely to be due to a number of factors. First, the size distributions of CNVs detected is dependent on the technology used. Second, given the probable differences in frequency of particular CNVs in different populations, the variety of different CNVs observable in a given study may be significantly limited by the number and ethnic origin of individuals examined. Third, the fraction of common CNVs (minor allele frequency >5%) may not be large, i.e. there may be many CNVs in the population of which most tend to be rare. Finally, the number of false positive and false negative CNVs in different studies may be variable, depending both on the measurement technology and the sample quality, including the sample source. For example many of the CNVs reported thus far have been discovered in DNA derived from cell-culture lines (4, 6, 8, 9) , which are known to be susceptible to genomic changes during propagation (19) .
In this report, we add a substantial number of new variations to the growing list of CNVs, and begin to address some of the issues listed above. We studied CNVs in a population of 50 apparently healthy, middle-aged Caucasian males of northern French origin, using genomic DNA derived from peripheral blood in order to avoid artefacts due to cell culture. We used high resolution array comparative genomic hybridisation (aCGH) with 60mer oligonucleotide probes, at an average spacing of 500 bp spanning 2475 regions of the genome identified in this study as putative CNV regions in this sample set. We also examined and contributed to the validation of 2,148 intervals previously reported as copy number variant regions (CNVRs) by determining the proportion that are variant in the study population.
We found 2208 CNVs detected by two or more probes (hereafter called multi-probe CNVs), clustering into 1469 copy number variant regions (CNVRs): of these, 721 CNVRs do not overlap regions already represented in the TCAG database of genomic variants. These 721 novel regions contain 367 genes, 150 of which are represented in the Online Mendelian Inheritance in Man (OMIM) database. The majority of CNVs that we observed are relatively small (66% < 20kb). We also found that the breakpoints of many CNVs are highly conserved between individuals, supporting the possibility that they might have high utility for association studies.
Results
We employed two different array designs for this study. The first was a 185K feature genome-wide scanning array, while the second was a focused custom 244K feature array designed to measure a large set of putative and known CNVs at high resolution. Throughout this paper, single-probe intervals describe those identified by a single probe on the array, and multi-probe intervals are those identified by 2 or more probes. Although it is often customary to report only intervals detected by more than one consecutive probe, there is evidence from our results that a significant proportion of the single-probe intervals called in this study represent real events, as outlined below. We have, therefore, included single-probe intervals in our analysis of the characteristics of the putative CNVs identified in this sample set.
In the first phase of the study, DNA derived from blood of a random subset (35) of the 50 apparently healthy, middle-aged white males of northern French origin were hybridised (in twocolour experiments with a pool of the 50 samples as the reference sample) to genome-wide microarrays comprising 185,000 60-mer oligonucleotide probes. These probes were designed for CGH, with an average spacing of 16kb, but with probe placement biased toward genes. Using the ADM-1 algorithm (20) with a threshold of 6 (relaxed stringency to ensure effective capture of putative CNVs), 1003 multi-probe variant intervals and 3777 single-probe variant intervals were detected ( Figure 1A , Supplementary Figure 1A and Material and Methods). Consistent with data from previous studies, variations detected using the genome-wide scanning arrays were distributed throughout the genome with the number of CNVs detected roughly proportional to the size of the chromosomes (Supplementary Figure 2) . We selected 2475 putative CNVRs for further investigation. These fell into three main categories as follows: all of the 1093 intervals that were either called in two or more samples by CGH Analytics common aberration analysis (21) with ADM-1 threshold of 6 or were found to have bimodal distributions of log 2 ratios across the 35 samples; 729 putative CNV intervals each found in a single sample; and a subset (653) of the regions that either exhibited tri-modal distribution of log 2 ratios across the 35 samples or were identified by CGH Analytics common aberration analysis with a less stringent ADM-1 threshold of 4.
For the second phase of the study, we designed a custom 244K feature focused array with a higher density of probes (spacing from 500-1500bp) within and flanking 2475 putative CNVRs from the first phase (described above) as well as probes in 2,148 intervals previously recorded as CNVRs in the October 2006 version of the TCAG Database of Genomic Variants (average spacing of 5Kb). Genomic DNA, from the 50 samples, was hybridised in two-colour experiments using an individual DNA sample (NA15510) as the reference. Analysis of the phase two data, using the ADM-2 algorithm (20, 22) with threshold 4, identified a total of 9244 multi-probe CNV intervals in the 50 samples, with a mean of 197 multi-probe intervals in each individual ( Figure 1B,   Supplementary Figure 1B ), compared to a mean of 10.3 in control self-self hybridisations (as described in Materials and Methods). The minimum number of multi-probe CNV intervals in any sample was 127, and the maximal number was 362 (Figure 2A ). In addition to the multi-probe CNVRs, there were also 6089 putative CNVs detected by single probes, 48% of which were observed in more than one individual (Supplementary Table 1 ). There was a median of 669 single probe intervals in each individual (compared to a mean of 29.6 in control self-self hybridisations) ( Figure 2B ).
The 9244 multi-probe variant intervals found in the 50 individuals were grouped into copy number variant regions (CNVRs) as described in the Materials and Methods Section and in Supplementary Figure 3 . We detected a total of 1469 multi-probe CNVRs, of which 1064 regions were definitely greater than 1kb and 405 regions were detected by two or more probes less than 1Kb apart, although their exact size was not defined (Table 1 and Supplementary Table 2) . A breakdown of the frequency distributions for these CNVRs is shown in Supplementary Figure 4 .
The median size of CNVRs was 4.4Kb, and large variations (of size more than 100kb) account for only 12% of CNVRs identified in this study, compared with 45% of variations reported in the TCAG database (Figure 3 ). Of the 6089 single-probe intervals discovered, a proportion are contained inside larger variations observed in other people, while 4705 are outside all of the multiprobe CNVRs identified in this study.
Novel regions
To assess what proportion of the variant regions discovered in this study were novel, we compared our data to those in the TCAG database (March 2007) (16) . In this study 748 multi-probe CNVRs (51%) overlapped loci reported in the TCAG database: 518 of these regions were completely contained within the corresponding TCAG variants and, therefore, have size defined as smaller than previously reported based on this cohort. Another 721 regions are not represented in the TCAG database. Of these 721 novel regions, 416 have sizes larger than 1Kb, and only 34 regions are larger than 100 Kb (Figure 3 ). Of the 4705 single probe intervals outside the multiprobe CNVRs identified, 2662 are potentially novel and do not overlap with regions reported in the TCAG database (Table 1) .
Similarly, we investigated what proportion of the total number of previously-reported CNVRs was detected in this population. The multi-probe CNVRs identified in our study overlapped 1735 of 6560 (26%) variations reported in the TCAG database (March 2007) (16) .
Confirmation and refinement of CNVs
Over 95% of the putative multi-probe CNVRs seen in two or more individuals using the phase one genome-wide 185K array were subsequently called as CNVRs using the phase two focused confirmation array. Of the common and bimodal single probe CNV intervals from phase one (ADM-1, threshold 6), 60% were validated as multi-probe calls by the focused phase two array data and an additional 30% of the phase one calls were again called by a single probe in second
phase. An example of a single probe call from phase one data confirmed in phase two by 12 probes is shown in Figure 1C .
We have also provided independent confirmation of 551 loci and 1735 variations in the TCAG database. In addition, we have provided detailed information on the boundaries of CNVs in the studied population (Supplementary Table 3 ), which contributes to refinement of mapping positions and boundaries of many variants. For example, in analysis of a CNVR that encompasses the FCGR3B gene, that has been shown to be associated with predisposition to glomerulonephritis (12, 23) , we were able to provide addition information about the extent and the structure of this CNV more definitively than in previous studies. We identified three CNVs (see Materials and Methods) in this region. Two variants showed only losses compared to the reference, a smaller variant of size 83.4Kb was observed in 18 samples and a larger variant of size 511.8Kb was observed in 16 samples ( Figure 4C ). The third, very small, variant (detected by 2 probes 238bp apart) was only observed in one individual and showed gain compared to the reference. We confirmed that, in addition to FCGR3B, the most common CNVR encompasses 5 other genes, (23) . Using mean log 2 ratios from the 168 probes across this region, it is possible to identify four distinct copy number states: multiple copy loss, single copy loss, copy number equivalency, and gain relative to the reference sample ( Figure 4B ). All samples with the larger variation were in the single copy loss cluster, while samples with the smaller variation were in both the single and multiple copy loss clusters.
In addition to confirmation of previously-reported variants by aCGH, we have validated 21 variant loci from this study using alternative methods, such as PCR across deletion breakpoints and detection of duplication by MLPA ( Figure 5 ). For example, we have confirmed by PCR a multiprobe deletion in 14 samples within the AKAP13 gene (A kinase anchor protein 13 = lymphoid blast crisis oncogene), showing both homozygous and heterozygous states in different samples (Supplementary Figure 5) . Also, we observed a novel 1.1Mb duplication on chromosome 7q34, encompassing 4 genes (PTN, DGK1, CREB3L2 and AKR1D1). Analysis of this region using multiplex probe ligation amplification (MLPA) on two daughters of the subject and their mother revealed that the two daughters inherited the copy number gain from the father ( Figure 5) . Despite having inherited an extra copy of all four genes, the two daughters were also apparently healthy.
Properties of multi-probe CNVRs
We next examined the degree to which different variants within the CNVRs observed in this study vary with regard to the length and position of the CNVs and/or their copy number states between different individuals. All of the individual CNV intervals observed were divided into a total 2208 copy number variants (Supplementary Table 3 and Supplementary Figure 3 ), assigning intervals observed in different individuals to the same copy number variant if they overlap by more than 50%, as described in Materials and Methods. Some regions of the genome show a high degree of complexity, with clusters of overlapping variants (Supplementary Figure 6 ) and others appear less complex, having only one variant (for example the region shown in Figure 1D ). Of 660
CNVRs observed in more than 1 sample, 387 regions had only one variant and 115 CNVRs had two or more variants, observed in two or more samples each.
The great majority of variants had common boundaries: the coefficient of variation of end points in the multi-probe CNVs observed in multiple samples is less than 0.1 for 83% of endpoints ( Figure 1D ). Variants tended to overlap by more than 90% if they overlapped at all. The complete distribution of overlap of multiprobe CNVs is shown in Supplementary Figure 7 .
Moreover, of the 1776 breakpoints of CNVs defined by multiple samples, 1142 endpoints were exactly the same, i.e. they ended at the same probe, in all samples that had copy number gain or loss at that position.
In the majority of multi-probe CNVRs, we observed only gains or only losses compared to the reference sample (rather than both gains and losses observed at the same locus). Specifically, 39% of variants showed only gains (compared to the reference sample), whereas 55% showed only losses. A mere 6% of variants had both gains and losses. Forty-two variants were determined to be homozygous deletions in the reference sample based on fluorescent signal distributions (See Materials and Methods).
To determine the proportion of multi-probe CNVs showing multiple copy number states (e.g. putative hemizygous and homozygous deletions, or the presence of multiple levels of copy number gain), we further analysed the relative frequency of different copy number states in 888
CNVs that were observed in three or more samples. In the majority of these CNVs only one alternative copy number state was observed. Of the regions with observed losses, 27 had two distinct peaks in the distribution of average log 2 ratios in samples with losses (p-value < 10 -6 ) indicating two distinct copy number loss events compared to the reference sample (for example, the FCGR region shown in Figure 4B ) and 294 CNVs had only one peak in average log 2 ratios corresponding to losses (for example, the chromosome 1 region shown in Figure 1E ). Eight regions had two distinct peaks in the distribution of average log 2 ratios in samples showing gains (p-value < 10 -8 ) indicating two distinct copy number gain events compared to the reference sample, compared to 235 regions having only one peak in the distribution of average log 2 ratios in the samples with gains (for example, the chromosome 1 region shown in Figure 1E ).
Genes in CNV regions
In CNVRs identified by multiple probes, we found 1653 unique genes: 368 (22%) of which were in novel CNVRs, while 1286 (78%) were in CNVRs already described in the TCAG database. In addition, we found a total of 1302 genes affected by the 6259 single-probe putative
CNVs in our population. Of these, 386 genes were also affected by multi-probe CNVRs (Supplementary Figure 8) . For 282 genes, exonic sequences were included; 129 of these genes showed variation at the same location in at least two people in our population. For genes with single-probe variations outside of the exons, 635 out of 1020 genes were affected in at least two people.
In order to investigate the potential biological consequences of the copy number variation that we observed in this study, we conducted a gene ontology (GO) analysis, which identifies overand under-represented categories for the genes in CNVRs. We generated three gene lists for comparison, consisting of genes in 1) TCAG CNVRs detected in this study, 2) novel CNVRs, and
3) all CNVRs observed in the study. In all three cases, association with the plasma membrane was identified as a highly significant category (Supplementary Table 4 ). We eliminated "cellular component" from the analysis to reduce the redundancy and to highlight the biological function for genes in the various categories of CNVRs (Table 2) .
Although the same GO categories were frequently represented in all three GO results sets, differences were observed ( Table 2 and Supplementary Table 4 ). For example, the GO categories with the highest significance for overrepresentation in the TCAG gene list are associated with sensory perception, while more general categories of differentiation and development top the GO categories of the genes in novel CNVs. In particular, nervous system development showed strong overrepresentation, along with functionally similar GO categories, such as transmission of nerve impulse and brain development (which comprised a different set of genes than those in nervous system development) ( Table 2 ). The majority of the differences between the TCAG GO results and the GO results from all CNVRs observed was driven by single-probe CNVs: in genes covered by the TCAG intervals, elimination of the 215 genes affected by single-probe CNVs had minimal effect on GO representation. Similarly, elimination of the 1302 genes with single-probe CNVs from the list of genes in all observed CNVRs generated GO results that were very similar to the TCAG GO results (Table 2 and Supplementary Table 4 ). Statistical significance of the GO overrepresentation associated with our novel CNVs was also highly influenced by the single-probe CNVs; the subtraction of the 197 genes in multi-probe CNVRs had minimal effect on the GO results in novel CNVRs (Supplementary Table 4 ). As might be expected, the GO results from all CNVRs reflect contributions from GO categories associated with both TCAG and novel CNVRs.
Almost half (150 out of 368) of the genes in novel multi-probe CNVRs were represented in the Online Mendelian Inheritance in Man (OMIM) (24) , suggesting that many genes in variant regions are likely to have disease relevance and/or biological importance. We observed instances where individuals in our sample population appeared to lack one of the copies of biologically important genes, such as the lipoprotein lipase gene (LPL), involved in receptor-mediated lipoprotein uptake (25) , and the carbonyl reductase 3 gene (CBR3), important in metabolising pharmacologically relevant carbonyl compounds (26) . We also found instances where individuals contain copy number gains of regulatory genes, such as NKX2-8, which encodes an nk2-related transcription factor associated with hepatocellular carcinomas (27) . Genes encoding another family of transcription factors known as the KRAB-Kruppel zinc fingers were also found in variant regions (including ZNF12, ZNF14, ZNF441, ZNF536 genes as well as closely associated ZNF165
and ZNF696); these transcription factors are strong repressors that are evolutionarily unstable, with a high degree of copy number variability between studied species (28) . Approximately half (634) of the genes that overlap single-probe variants anywhere in the gene were also represented in OMIM (of which 73 had exonic variants that were found in more than one person). Within this list is an assortment of genes of interest to human health, such as the cancer-relevant MEN1, APC, and IGFIR as well as genes potentially associated with other complex phenotypes, including congenital malformations, neurological and psychiatric disorders.
Discussion
We report discovery of a large number of novel copy number variations in the genomes of healthy adults. Many of these affect genes and, thus, may have important implications for subtle, quantitative, or late-onset phenotypes. The measurement platform that we have used is designed to enable detection of small as well as larger CNVs, allowing us systematically to study the size distributions of a large number of previously identified and novel CNVs in more detail than many previous studies. Twenty-eight percent of the CNVRs detected in our sample set were detected by probes less than 1Kb apart suggesting that a larger proportion of copy number variation between individuals may reside in smaller intervals than previously reported. Outside these CNVRs, an additional 4705 variations were identified by single probes, 1587 of them even when probe spacing was as close as 500 bp. Although we have excluded from our analysis probes that may contain restriction cut sites created by known single nucleotide polymorphisms (SNPs) (as explained in Materials and Methods), it is possible that some of the single probe calls could be related to sequence variants, rather than variation in copy number. We did, however, observe a high confirmation rate of regions that had been identified by single probes in the first phase of the study in the second stage: 60% of single probe intervals were converted to multi-probe intervals and 30%
were detected again by a single probe. It is clear that the high resolution of the second stage array This is one of the highest resolution genome-wide studies to date, with the custom array having probes located only 500bp apart in many regions. This has allowed us to more precisely refine the mapping of the boundaries of many known and novel CNVRs. A large proportion of the CNVs we measured appear to have common boundaries between individuals. There is however, a variety of more complex cases. In these instances it appears that intervals of different sizes mapping to the same region of the reference genome are variant between individuals. Specific study of complex regions will be necessary to elucidate the genome organization and structure of the sequences within these regions.
In addition to refining our understanding of structural diversity between individuals, more precise knowledge of the breakpoints of CNVs enables a more accurate accounting of the genes and regulatory regions impacted by copy number variation. Many genes are affected by copy number variation, and many such variants are at high frequency in the studied population. shown that genes involved in fertility and reproduction are subject to rapid adaptive evolution in primates due to sexual competition and defence against pathogens (33) : all of these gene groups are overrepresented in CNVs. Additionally, we found strong overrepresentation of genes involved in development (particularly of the nervous system) and differentiation. Evidence from other sources supports the importance of large-scale chromosomal alterations in human evolution: for example, a common inversion at chromosome 17q21.31 is thought to be under positive selection in Europeans, having been associated with recombination rate and with increased numbers of children (35) . In the case of CNVs, selective pressure can be observed in current human populations, for example CCL3L1 variation is associated with susceptibility to HIV/AIDS, and CYP2D6 variations affect drug metabolism (resulting in variation in effective dose and rate of adverse effects) respectively, (11, 36) .
The same plasticity of the human genome that has contributed to its evolution may also result in the formation of detrimental genomic mutations (37) . There is evidence for this with respect to the 17q21.31 inversion, mentioned above, where microdeletions in the same region lead to a mental retardation syndrome (38) . The results of our study will be of interest to clinical cytogeneticists hoping to use aCGH technology to uncover cryptic chromosomal imbalances in patients. Conventionally, smaller aberrations and, particularly, single probe signals have been regarded as artefactual -we provide evidence that in many cases these may be real, common and affect important genes. Similarly, large variants affecting multiple genes have been regarded as more likely to be pathogenic. While this may generally be true, the fact that a >1Mb duplication encompassing four genes, is present in the genome of an apparently healthy individual and his two daughters, highlights the necessity of documenting all CNVs discovered. Cytogeneticists need to know which are likely to be phenotypically neutral in order to assess which aberrations may be responsible for congenital malformations and learning disability in patients with suspected genomic disorders. Genomic disorders are rare, but CNVs, particularly those that are common and affect coding sequences or regulatory regions, may have wider implications for human health, with subtle variations in phenotype having important consequences for complex disease, such as cancer, neuropsychiatric diseases, obesity and diabetes. This concept is exemplified by the association of copy number polymorphism in FCGR genes with organ-specific immunity (12, 23) , and associations of other CNVs with autism (13, 14) and with host response to HIV (11) . Our study provides a significant refinement to the existing map of genetic differences and potentially affected genes. A more complete map of CNVs is a critical step in understanding the biological relevance of human genomic variation and evaluation of the contribution of CNVs to common diseases.
Materials and Methods

DNA samples
DNA samples were isolated from peripheral blood of 50 unrelated, apparently healthy white males of northern French origin using Puregene kits (Gentra, USA) and resuspended in Tris -EDTA buffer. For analysis of Mendelian transmission, DNAs from three family members (spouse and two daughters) of one particular subject were also purified from peripheral blood -these subjects were also apparently healthy Caucasians from northern France. For the first phase of the study using the genome-wide 185K array, a pooled reference sample was generated by combining an equal mass of genomic DNA from all 50 subjects. After phase I of the study, it became clear that many more CNVs than anticipated were common in the population and, thus, there would be loss of power to detect them using a pooled reference. For this reason, it was considered preferable to switch to a single reference for the second phase. The particular sample chosen, obtained from the Coriell Cell Repository, was derived from a north American female of unknown ethnic origin (NA15510). This sample has been extensively characterised and is recommended for use in CNV detection programmes to allow meaningful comparison of data between studies (discussed in Scherer et al. (39) ). All samples had ethical committee approval for use in this study.
Microarray Design
Microarrays used in this study were 60mer in situ synthesised oligonucleotide arrays designed and produced by Agilent Technologies (Santa Clara, CA). Two array designs were employed. The first was a genome-wide CGH array consisting of 185,000 probes nominally spaced evenly across the genome with average probe spacing of 16kb, but with a bias toward known genes. The second array was a custom focused array containing 244,000 probes selected For these 19 individuals, all calls were included in phase 2. These probes were added to explore different categories of regions detected on the genome-wide array, but not necessarily observed in a significant number of samples or with a more stringent threshold.
Microarray Labelling and Hybridisation
All array hybridisations were carried out according to the manufacturer's recommended protocols (40). Briefly, 500ng of genomic DNA was digested with restriction enzymes AluI and RsaI and fluorescently labelled using the Agilent DNA Labelling kit. T-test samples were labelled with Cyanine 5-dUTP and the reference sample with Cyanine 3-dUTP. Labelled DNA was denatured and pre-annealed with Cot-1 DNA and Agilent blocking reagent prior to hybridization for 40 hours at 20 rpm in a 65°C oven. Standard wash procedures were followed. Arrays were scanned at 5μm resolution using an Agilent scanner, and image analysis was performed using default CGH settings of Feature Extraction Software 9.1.1.1 (Agilent Technologies).
Statistical analysis
Putative copy number variant intervals in each sample were identified using Agilent CGH Analytics 3.4 software (41) and Matlab-based tools using the same statistical methods and algorithmic approaches. All regions of statistically significant copy number change were determined using ADM (aberration detection module) algorithms (20, 22) . The ADM algorithms identify genomic regions with copy number differences between the sample and the reference based on log 2 ratios of fluorescent signals from probes in the interval. In brief, ADM algorithms use an iterative procedure to identify all genomic regions with the deviation of average of the measured signals in a given region from its expected value of 0 larger than a given threshold. This deviation is measured by a statistical score. At each iteration, the region with the most significant score is reported.
Throughout this paper, single-probe intervals describe putative CNVs identified by 1 probe on the array, and multi-probe intervals are those identified by 2 or more probes. Boundaries and sizes of intervals are defined based on positions of the last and the first microarray probes in the interval.
In order to capture a wide range of putative CNVs in the discovery stage, the genome-wide scanning array data were analysed using the less stringent ADM-1 algorithm at threshold 6. In a pre-processing step, features with log ratio error > 0.5 (in log 2 scale) were filtered out.
Centralisation and fuzzy zero corrections were applied to remove putative variant intervals with small average log 2 ratios. Aberrations common to two or more samples were identified by context corrected common aberration analysis in CGH Analytics 3.4 (21) . Bimodal probes were defined by the following criteria: probes were called bimodal if log 2 ratios for this probe across 35 samples could be separated into two groups with significantly different averages as determined by a twosample t-test (p-value < 10 -14
). Trimodal probes were defined as probes that were not bimodal, and for which the log 2 ratios across 35 samples could be divided into three groups with significantly different averages by ANOVA analysis.
For the second phase, data from the focused confirmation array were analysed using the ADM-2 algorithm at threshold 4. The ADM-2 algorithm uses log 2 ratios weighted by log 2 ratio error as calculated by Feature Extraction software to identify genomic intervals with copy number differences between the sample and the reference. Data was centralised, and calls with average log 2 ratios less than 0.3 were excluded from the analysis, as were any calls detected by probes containing a known SNP that may alter an AluI or RsaI restriction site as determined by the 9.3 million in the UCSC annotation database for the genome browser (42) .
The false positive rate for the ADM-2 algorithm at threshold 4 was determined using 3 self- The false negative rate was estimated in a similar manner to that described by Wong et al. After putative variant intervals were identified in each sample, we used the following iterative procedure to determine the boundaries of copy number variant regions as illustrated in Supplementary Figure 3 . At each iteration, we identified a genomic locus g that was overlapped by the largest number of per-sample variant intervals. Each interval had to extend at least 250bp to each side of the selected locus g . Copy number variant region (CNVR) R corresponding to g was defined as the union of per sample intervals overlapping g. Per-sample intervals overlapping g and other intervals completely contained in R were excluded from the next iteration of the algorithm.
Iteration steps were repeated until all per-sample intervals were combined into CNVRs.
Per-sample intervals corresponding to each CNVR were further clustered to define copy number variants corresponding to each region. Each cluster contained per-sample intervals with pair-wise overlap of at least 0.5. Boundaries of each copy number variant cluster were defined as median endpoints of its members.
Average log 2 ratios of intervals showing gains and losses corresponding to each copy number variant were further analysed to identify distinct copy number states. Using a two sample Student t-test, we identified intervals for which the average log 2 ratios for gains/losses can be divided into 2 groups with significantly different means. In addition, a one sample Student t-test was used to test that the distribution of all average log 2 ratios for gains/losses is significantly different from 0.
Copy number variant intervals called in different samples can differ in the genomic intervals that they span as well as in the level at which their copy number differs from that of the reference sample. We analysed the data to determine the observed instances of both types of variations. We use the term CNV to refer to variants that differ in length while CNVs that differ in copy number between individuals are referred to as having different copy number states.
Homozygous deletions in the reference sample were determined based on the absolute signal intensity in the reference channel and on the relative signal intensity in the reference channel compared to signals across all samples. Variants were determined to be homozygous deletions in the reference sample if either of the following was true. The median Processed Signal of the reference channel for probes within the variant was less than 100 when averaged across all arrays (where the Processed Signal is normalised across each array to have a median value of 1000); or the average reference channel signal for that region was more than 4-fold lower (log 2 ratio < -2)
than the average signal for all samples.
GO Analysis was conducted using GOstat which finds statistically overrepresented Gene
Ontology terms within a group of genes to generate a list of over-represented GO terms (43).
False Discovery Rate was selected to correct for multiple testing (44) .
Multiplex ligation-dependent probe amplification (MLPA)
MLPA was carried out to validate a large duplication, in order to determine its breakpoints more precisely, and to investigate its Mendelian transmission. Oligonucleotide probe pairs for ligation were designed following the MRC-Holland guidelines for MPLA (Supplementary Table 5) (45). All MLPA reagents were obtained from MRC-Holland, and all reactions were performed as previously described (46) . Briefly, DNA samples were heat-denatured in a thermocycler at 98°C for 5 minutes, and hybridisation of the probes carried out in an overnight incubation at 60°C.
Ligation reactions were then carried out using Ligase-65 mix, and PCR amplification of the ligated probes performed using a SALSA Polymerase mix, which included universal MLPA primers: 5′ FAM-labelled primer (GGGTTCCCTAAGGGTTGGA) and 3′ primer (TCTAGATTGGATCTTGCTGGCAC). Two control probes previously validated in another study were included in each experiment (47) . MLPA products were separated using an AB 3730x1 DNA normalisation and analysis of peak ratios to determine the copy number of each region was subsequently performed using Microsoft Excel.
PCR-based validation
Validation of 20 deletion polymorphisms was carried out by PCR amplification with paired probe sets spanning and within the deleted region. Primers were designed using Primer3 software (48) (sequences available on request). PCR was carried out using standard methods and products were examined by agarose gel electrophoresis. Supplementary Table 5 . MLPA synthetic probes. The 5′ half-probes are preceded by the 5′ FAM-labelled universal primer tag, and 3′ half-probes are preceded by a 5′ phosphate group and followed by the 3′ universal primer tag (see 
